Andrew D Seidman MD

Oncology•New York, NY

Professor, Medicine, Weill Cornell Medical College

Request appointment

300 East 66th StreetFloors 1 - 4New York, NY 10065
Book by Phone+1(361) 306-5348

Overview of Dr. Seidman

Dr. Andrew Seidman is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. He received his medical degree from Drexel University College of Medicine and has been in practice 41 years. Dr. Seidman accepts several types of health insurance, listed below. He is one of 529 doctors at Memorial Sloan Kettering Cancer Center and one of 403 doctors at New York-Presbyterian Hospital who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 1985 - 1988
Drexel University College of MedicineClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1989 - 2028
NJ State Medical License 2020 - 2027
FL State Medical License 2019 - 2021
PA State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017

Clinical Trials

Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic Start of enrollment: 1998 Jul 01
Completed
Phase 3
Paclitaxel Plus Monoclonal Antibody Therapy in Treating Women With Recurrent or Metastatic Breast Cancer Start of enrollment: 1998 Apr 01
Completed
Phase 2
Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 Start of enrollment: 2000 Jan 01
Completed
Phase 2

Publications & Presentations

PubMed

11 citations
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical Trial.
Jonathan T Yang, Divya Yerramilli, Elena Pentsova, Suzanne Wolden, Robert J Young
JAMA Oncology. 2025-11-01
1 citations
Clinicopathological features of microinvasive lobular carcinoma.
Rachel Han, Atif A Hashmi, Hannah Y Wen, Melissa Murray, M Gabriela Kuba
Histopathology. 2025-08-01
1 citations
Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis.
Celine Yeh, Rachel Han, Abha Kulkarni, Charlie White, Yuan Chen
NPJ Breast Cancer. 2025-05-24

Authored Content

A Phase IIA Trial of Acupuncture to Reduce Chemotherapy-Induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer PatientsAugust 2018

Press Mentions

Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)December 11th, 2020
Odonate Therapeutics Announces Positive Top-Line Results from CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast CancerAugust 24th, 2020
Selected Abstracts from the San Antonio Breast Cancer SymposiumFebruary 11th, 2019

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref
Please verify your coverage with the provider's office directly when scheduling an appointment